EDESA BIOTECH, INC. Interest Income, Other
EDESA BIOTECH, INC. (EDSA) reported Interest Income, Other of $275 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-08-13
- EDESA BIOTECH, INC. interest income, other for the quarter ending 2026-06-30 was $275.00, a 51.92% decline year-over-year.
- EDESA BIOTECH, INC. interest income, other for the quarter ending 2026-03-31 was $639.00, a 141.13% increase year-over-year.
- EDESA BIOTECH, INC. interest income, other for the quarter ending 2025-12-31 was $47.00, a 97.18% decline year-over-year.
- EDESA BIOTECH, INC. interest income, other for the quarter ending 2025-09-30 was $55.00, a 99.67% decline year-over-year.
- EDESA BIOTECH, INC. interest income, other for fiscal 2025 was $2.56K, a 98.33% decline from fiscal 2024.
- EDESA BIOTECH, INC. interest income, other for fiscal 2024 was $153.50K, a 47.04% decline from fiscal 2023.
- EDESA BIOTECH, INC. interest income, other for fiscal 2023 was $289.85K, a 356.29% increase from fiscal 2022.
- EDESA BIOTECH, INC. interest income, other for fiscal 2022 was $63.52K, a 468.95% increase from fiscal 2021.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2026-06-30 | $275.00 10-Q · filed 2026-08-13 | $914.00 derived: sum of 2 quarters · filed 2026-08-13 | $961.00 10-Q · filed 2026-08-13 | $1.02K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $639.00 10-Q · filed 2026-05-14 | $686.00 10-Q · filed 2026-05-14 | $741.00 derived: sum of 3 quarters · filed 2026-05-14 | $1.31K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $47.00 10-Q · filed 2026-02-13 | $102.00 derived: sum of 2 quarters · filed 2026-02-13 | $674.00 derived: sum of 3 quarters · filed 2026-08-13 | $939.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $55.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | $627.00 derived: sum of 2 quarters · filed 2026-08-13 | $892.00 derived: sum of 3 quarters · filed 2026-08-13 | $2.56K 10-K · filed 2025-12-12 |
| 2025-06-30 | $572.00 10-Q · filed 2026-08-13 | $837.00 derived: sum of 2 quarters · filed 2026-08-13 | $2.50K 10-Q · filed 2026-08-13 | $18.99K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $265.00 10-Q · filed 2026-05-14 | $1.93K 10-Q · filed 2026-05-14 | $18.42K derived: sum of 3 quarters · filed 2026-05-14 | $51.27K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.67K 10-Q · filed 2026-02-13 | $18.16K derived: sum of 2 quarters · filed 2026-02-13 | $51.01K derived: sum of 3 quarters · filed 2026-02-13 | $94.20K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $16.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | $49.34K derived: sum of 2 quarters · filed 2025-12-12 | $92.53K derived: sum of 3 quarters · filed 2025-12-12 | $153.50K 10-K · filed 2025-12-12 |
| 2024-06-30 | $32.85K 10-Q · filed 2025-08-08 | $76.04K derived: sum of 2 quarters · filed 2025-08-08 | $137.01K 10-Q · filed 2025-08-08 | $208.95K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $43.19K 10-Q · filed 2025-05-14 | $104.16K 10-Q · filed 2025-05-14 | $176.10K derived: sum of 3 quarters · filed 2025-05-14 | $258.86K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $60.97K 10-Q · filed 2025-02-14 | $132.91K derived: sum of 2 quarters · filed 2025-02-14 | $215.66K derived: sum of 3 quarters · filed 2025-02-14 | $301.38K derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | $71.94K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-13 | $154.70K derived: sum of 2 quarters · filed 2024-12-13 | $240.42K derived: sum of 3 quarters · filed 2024-12-13 | $289.85K 10-K · filed 2024-12-13 |
| 2023-06-30 | $82.75K 10-Q · filed 2024-08-09 | $168.47K derived: sum of 2 quarters · filed 2024-08-09 | $217.90K 10-Q · filed 2024-08-09 | $254.04K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $85.72K 10-Q · filed 2024-05-10 | $135.15K 10-Q · filed 2024-05-10 | $171.28K derived: sum of 3 quarters · filed 2024-05-10 | $188.80K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $49.43K 10-Q · filed 2024-02-09 | $85.57K derived: sum of 2 quarters · filed 2024-02-09 | $103.08K derived: sum of 3 quarters · filed 2024-02-09 | $106.83K derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-09-30 | $36.14K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | $53.66K derived: sum of 2 quarters · filed 2023-12-15 | $57.40K derived: sum of 3 quarters · filed 2023-12-15 | $63.52K 10-K · filed 2023-12-15 |
| 2022-06-30 | $17.52K 10-Q · filed 2023-08-09 | $21.27K derived: sum of 2 quarters · filed 2023-08-09 | $27.39K 10-Q · filed 2023-08-09 | $34.27K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $3.75K 10-Q · filed 2023-05-11 | $9.87K 10-Q · filed 2023-05-11 | $16.75K derived: sum of 3 quarters · filed 2023-05-11 | $19.36K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $6.12K 10-Q · filed 2023-02-10 | $13.01K derived: sum of 2 quarters · filed 2023-02-10 | $15.62K derived: sum of 3 quarters · filed 2023-02-10 | $16.36K derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-09-30 | $6.89K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-16 | $9.50K derived: sum of 2 quarters · filed 2022-12-16 | $10.24K derived: sum of 3 quarters · filed 2022-12-16 | $11.16K 10-K · filed 2022-12-16 |
| 2021-06-30 | $2.61K 10-Q · filed 2022-08-12 | $3.36K derived: sum of 2 quarters · filed 2022-08-12 | $4.28K 10-Q · filed 2022-08-12 | $5.29K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $747.00 10-Q · filed 2022-05-13 | $1.67K 10-Q · filed 2022-05-13 | $2.69K derived: sum of 3 quarters · filed 2022-05-13 | $6.48K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $922.00 10-Q · filed 2022-02-14 | $1.94K derived: sum of 2 quarters · filed 2022-02-14 | $5.74K derived: sum of 3 quarters · filed 2022-02-14 | |
| 2020-09-30 | $1.02K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28 | $4.82K derived: sum of 2 quarters · filed 2021-12-28 | $37.78K 10-K · filed 2021-12-28 | |
| 2020-06-30 | $3.80K 10-Q · filed 2021-08-13 | $36.76K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |